Study to assess the safety and preliminary efficacy of AZD0156 at increasing doses alone or in combination with other anti-cancer treatment in patients with advanced cancer

Trial Identifier: D6500C00001
Sponsor: AstraZeneca
Collaborator:
INC Research
NCTID:: NCT02588105
Start Date: November 2015
Primary Completion Date: September 2019
Study Completion Date: July 2022
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Spanish Version
Korean Version

Trial Locations

Country Location
ES Barcelona, ES, 08035
GB Manchester, GB, M20 4BX
KR Seoul, KR, 03080
US, CO Aurora, CO, US, 80045
US, NY New York, NY, US, 10033